Aether and Procter & Gamble Begin 3D Printing and AI Development Project
19 févr. 2019 10h53 HE
|
Aether
SAN FRANCISCO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aether, the pioneer of AI enhanced 3D printing and bioprinting, today announced the commencement of a two year joint development agreement with...
BIOLIFE4D Appoints Management Advisory Board
28 janv. 2019 08h30 HE
|
BIOLIFE4D Corporation
CHICAGO, Jan. 28, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has established a...
BIOLIFE4D Successfully Demonstrates Ability to 3D Bioprint Human Cardiac Tissue
25 juin 2018 08h00 HE
|
BIOLIFE4D Corporation
CHICAGO, June 25, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully...
BIOLIFE4D Modifies its Regulation A+ (Mini-IPO) Offering Due to Popular Demand
23 juin 2018 08h00 HE
|
BIOLIFE4D Corporation
CHICAGO, June 23, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it will be modifying...
BIOLIFE4D Establishes Operations in Houston as Part of Commercialization Strategy for Life-Saving 3D Bioprinting Technology
29 mai 2018 08h02 HE
|
BIOLIFE4D Corporation
CHICAGO, May 29, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it is now a resident...
BIOLIFE4D Signs Laboratory Service Agreement with Northwestern University
05 févr. 2018 08h01 HE
|
BIOLIFE4D Corporation
CHICAGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has signed a...
BIOLIFE4D Launches Regulation A+ (Mini-IPO) Offering; Plans to Raise $50M
01 févr. 2018 06h00 HE
|
BIOLIFE4D Corporation
CHICAGO, Feb. 01, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched a...
BIOLIFE4D Targets High Growth Healthcare 3D Printing Market as it Readies for Regulation A+ Offering
17 janv. 2018 07h32 HE
|
BIOLIFE4D Corporation
CHICAGO, Jan. 17, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today commented on the high growth...
BIOLIFE4D Names Dr. Ravi Birla as its Chief Science Officer
02 janv. 2018 08h01 HE
|
BIOLIFE4D Corporation
CHICAGO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has named Dr....